|
|
|||||||
Case Reports |
Department of Human Biopathology, University La Sapienza, Rome, Italy.
We studied a patient who developed pure red cell aplasia (PRCA) following peripheral stem cell transplantation for non-Hodgkin lymphoma. Serum erythropoietin was appropriate for the degree of anemia. Corticosteroid treatment was ineffective. Four months after transplantation rHuEpo was administered subcutaneously at a dose of 150 U/Kg per day, five days a week for 8 weeks. Treatment induced an erythropoietic response and corrected anemia. Response was maintained following discontinuation of rHuEpo. This study and previous reports indicate that high doses of rHuEpo given over a short time can resolve PRCA following autologous or allogeneic stem cell transplantation.
This article has been cited by other articles:
![]() |
C. D. Bolan, S. F. Leitman, L. M. Griffith, R. A. Wesley, J. L. Procter, D. F. Stroncek, A. J. Barrett, and R. W. Childs Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation Blood, September 15, 2001; 98(6): 1687 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cazzola, R. Guarnone, P. Cerani, E. Centenara, A. Rovati, and Y. Beguin Red Blood Cell Precursor Mass as an Independent Determinant of Serum Erythropoietin Level Blood, March 15, 1998; 91(6): 2139 - 2145. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cazzola, F. Mercuriali, and C. Brugnara Use of Recombinant Human Erythropoietin Outside the Setting of Uremia Blood, June 15, 1997; 89(12): 4248 - 4267. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |